网站主页
抗-DNA-RNA杂交抗体,克隆S9.6
抗-DNA-RNA杂交抗体
Anti-DNA:RNA hybrid抗体[clone:S9.6]
Anti-DNA-RNA Hybrid Antibody(S9.6) (RGK60001)
¥2300
1支
起订
湖北 更新日期:2024-04-28
产品详情:
- 中文名称:
- 抗-DNA-RNA杂交抗体
- 英文名称:
- Anti-DNA-RNA Hybrid Antibody(S9.6) (RGK60001)
- 品牌:
- AS
- 产地:
- 法国
- 保存条件:
- -20°C
- 纯度规格:
- PAGE:>95%
- 产品类别:
- 一抗 InVivo活性抗体
- 抗体名:
- Anti-DNA-RNA Hybrid Antibody(S9.6) (RGK60001)
- 靶点:
- DNA-RNA,antibody,抗体
- 宿主:
- mouse
- 适应物种:
- General
- 克隆性:
- Monoclonal
- 货号:
- RGK60001
- 货号::
- RGK60001
- 应用::
- CHIP, ChIP-seq, DB, EMSA, FISH, ICC, IP, SPR, IF
- 描述:
- DNA-RNA hybrids are a natural occurrence within eukaryotic cells and their level are high at sites of high transcriptional activity. They are non-canonical nucleic acid structures with transcriptional regulatory functions. Their presence is reported to predispose a locus to chromosomal breakage. A locus forming an DNA:RNA creates a double-stranded A/B intermediate conformation, with a second target for single-stranded nucleic acid binding proteins on the complementary, displaced DNA strand. They are shown to be resistant to the activity of DNA methyltransferases. The formation of DNA:RNA hybrids has been associated with a number of neurological diseases. Mutations in the DNA:RNA helicase senataxin (SETX) are implicated in the dominant juvenile form of amyotrophic lateral sclerosis type 4 and a recessive form of ataxia oculomotor apraxia type 2.
公司简介
普健生物依托自主研发的高通量活性蛋白表达系统,Single B细胞抗体发现技术平台,噬菌体展示抗体库技术和杂交瘤抗体开发平台,抗体表达、抗体人源化和稳定细胞株构建平台,与各研究机构展开技术服务项目合作,助力IVD检测、疫苗生产、重组抗体开发。
普健生物一站式抗体发现平台,专注于活性蛋白,功能性抗体开发。
成立日期 | (13年) |
注册资本 | 1071.083万人民币 |
员工人数 | 100-500人 |
年营业额 | ¥ 1000万-5000万 |
经营模式 | 试剂 |
主营行业 | 生物化工,技术服务 |
抗-DNA-RNA杂交抗体相关厂家报价
- 人抗单链DNA抗体/变性DNA抗体(ssDNA)Elisa试剂盒
- 上海彩佑实业有限公司 VIP
- 2024-04-29
- ¥1200
- RNA聚合酶III抗体
- 上海一研生物科技有限公司 VIP
- 2024-04-30
- 询价
- Anti-RNA polymerase IIantibody -RNA聚合酶II抗体
- 上海沪震实业有限公司 VIP
- 2024-04-30
- ¥1098